Nagai H - Search Results

1

Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients.

Masago K, Fujita S, Kim YH, Ichikawa M, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Mio T, Mishima M. Masago K, et al. Among authors: nagai h. Cancer Genet Cytogenet. 2009 Dec;195(2):179-82. doi: 10.1016/j.cancergencyto.2009.06.025. Cancer Genet Cytogenet. 2009. PMID: 19963121 No abstract available.

2

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.

Masago K, Fujita S, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Ichikawa M, Mio T, Mishima M. Masago K, et al. Among authors: nagai h. Cancer Sci. 2009 Oct;100(10):1917-22. doi: 10.1111/j.1349-7006.2009.01253.x. Epub 2009 Jun 23. Cancer Sci. 2009. PMID: 19594543 Free PMC article.

3

Association of the transforming growth factor ß1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancer.

Togashi Y, Masago K, Fujita S, Kim YH, Sakamori Y, Hatachi Y, Fukuhara A, Nagai H, Mio T, Mishima M. Togashi Y, et al. Among authors: nagai h. Oncol Rep. 2011 Feb;25(2):377-82. doi: 10.3892/or.2010.1098. Epub 2010 Dec 10. Oncol Rep. 2011. PMID: 21165571

4

Clinicopathologic factors affecting the progression-free survival of patients with advanced non-small-cell lung cancer after gefitinib therapy.

Masago K, Fujita S, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Sakamori Y, Mio T, Mishima M. Masago K, et al. Among authors: nagai h. Clin Lung Cancer. 2011 Jan;12(1):56-61. doi: 10.3816/CLC.2011.n.008. Clin Lung Cancer. 2011. PMID: 21273181

5

Differences in adverse events between 250 mg daily gefitinib and 150 mg daily erlotinib in Japanese patients with non-small cell lung cancer.

Togashi Y, Masago K, Fujita S, Hatachi Y, Fukuhara A, Nagai H, Sakamori Y, Kim YH, Mio T, Mishima M. Togashi Y, et al. Among authors: nagai h. Lung Cancer. 2011 Oct;74(1):98-102. doi: 10.1016/j.lungcan.2011.01.022. Epub 2011 Mar 5. Lung Cancer. 2011. PMID: 21377230

6

Clinical significance of pretreatment C-reactive protein in patients with advanced nonsquamous, non-small cell lung cancer who received gefitinib.

Masago K, Fujita S, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Sakamori Y, Okuda C, Mio T, Mishima M. Masago K, et al. Among authors: nagai h. Oncology. 2010;79(5-6):355-62. doi: 10.1159/000323486. Epub 2011 Mar 24. Oncology. 2010. PMID: 21430404

7

Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancer.

Masago K, Fujita S, Togashi Y, Kim YH, Hatachi Y, Fukuhara A, Nagai H, Irisa K, Sakamori Y, Mio T, Mishima M. Masago K, et al. Among authors: nagai h. Oncol Rep. 2011 Oct;26(4):795-803. doi: 10.3892/or.2011.1354. Epub 2011 Jun 17. Oncol Rep. 2011. PMID: 21805046 Clinical Trial.

8

Increase in circulating endothelial progenitor cells predicts response in patients with advanced non-small-cell lung cancer.

Sakamori Y, Masago K, Ohmori K, Togashi Y, Nagai H, Okuda C, Kim YH, Ichiyama S, Mishima M. Sakamori Y, et al. Among authors: nagai h. Cancer Sci. 2012 Jun;103(6):1065-70. doi: 10.1111/j.1349-7006.2012.02249.x. Epub 2012 Apr 15. Cancer Sci. 2012. PMID: 22360644 Free PMC article.

9

Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.

Togashi Y, Masago K, Handa T, Tanizawa K, Okuda C, Sakamori Y, Nagai H, Kim YH, Mishima M. Togashi Y, et al. Among authors: nagai h. Clin Lung Cancer. 2012 Jul;13(4):304-11. doi: 10.1016/j.cllc.2011.11.001. Epub 2011 Dec 13. Clin Lung Cancer. 2012. PMID: 22169479 Free article.

10

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer.

Togashi Y, Masago K, Masuda S, Mizuno T, Fukudo M, Ikemi Y, Sakamori Y, Nagai H, Kim YH, Katsura T, Mishima M. Togashi Y, et al. Among authors: nagai h. Cancer Chemother Pharmacol. 2012 Sep;70(3):399-405. doi: 10.1007/s00280-012-1929-4. Epub 2012 Jul 18. Cancer Chemother Pharmacol. 2012. PMID: 22806307 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,671 results

Search Page

Filters